Approaching spatial proteomics by mass spectrometry means engaging with a trade-off that governs every workflow in this area: proteome depth is bought with material. More tissue gives more proteins and less spatial precision, and no amount of instrument sensitivity removes that relationship. Understanding where each approach sits on that curve is more useful than any capability list.
Key Takeaways
|
MS or Antibodies? What Each Actually Targets
The usual framing is that antibody imaging detects proteins you chose in advance while mass spectrometry discovers what is present. That is accurate about the measurement and incomplete about the workflow, and the incompleteness matters when you are choosing between them.
The clarification comes from the developers of the leading MS-based approach. Describing single-cell Deep Visual Proteomics, they note that the method depends by its nature on prior knowledge of adequate markers of the cells of interest that resolve their heterogeneity. Cells are identified for excision using stains and morphological features chosen in advance. So the proteome measurement is untargeted while the cell selection is guided by markers.
| Antibody-Based Imaging | MS-Based Spatial Proteomics |
What is targeted | The analyte. You detect the proteins whose antibodies you applied | Frequently the cell. Selection is marker-guided, but the proteins measured are not pre-specified |
Discovery capability | None beyond the panel. A protein without an antibody in the panel is invisible | Genuine. Thousands of proteins can be quantified without prior specification |
Post-translational modifications | Only where a modification-specific antibody exists | Accessible in principle, since modified peptides differ in mass |
Proteoforms and isoforms | Generally not distinguished | Distinguishable where peptides differ |
Spatial resolution | Subcellular, and preserved across the whole section | Set by dissection precision or pixel size rather than by the mass spectrometer |
Sensitivity for a known target | High. Amplification and specific binding favour the antibody | Lower for any individual protein at equivalent material |
Reagent development burden | Substantial. Antibody validation and conjugation per marker | None. No affinity reagents required |
Table 1. What each approach actually targets. The first row is the distinction usually missed: both approaches involve prior choices, but at different stages of the workflow.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
The practical consequence is that these are complementary rather than ranked. If you know which twenty proteins matter and need them localised sensitively across a whole section, antibody imaging is the better tool. If you need to know what is present in a defined region without specifying it in advance, or you care about modifications and proteoforms, mass spectrometry is the only route. For high-plex antibody work, the reagent burden is real: a review of high-plex biomarker assessment identifies time-consuming antibody conjugation and assay optimisation alongside challenging data processing as characteristic requirements.
One point of overlap worth noting to avoid confusion. Mass spectrometry can also be used in a fully targeted mode, by staining tissue with antibodies carrying unique mass reporters and reading those reporters. That is a mass spectrometry technique that behaves conceptually like an antibody method, and it belongs in the left column of Table 1 rather than the right.
Laser Capture Microdissection With LC-MS
This is the workhorse of the field and the approach most laboratories can adopt without new instrumentation. Its logic is straightforward: excise a defined region of tissue, then run a conventional deep proteomics workflow on it.
Three features make it attractive, and one constrains it.
- Spatial resolution is set by the dissection, not the mass spectrometer. You decide what a sample is by drawing around it, which means resolution is limited by microdissection precision rather than by any spectrometric parameter.
- Coverage is that of a normal experiment. Because the excised material enters a conventional liquid chromatography and tandem MS workflow, the depth achievable is far greater than direct imaging of the same tissue.
- It uses instrumentation many laboratories already have. The additional requirement is a microdissection microscope and low-input sample handling rather than a dedicated imaging platform.
- Low input is the hard part. Small excised volumes mean small protein amounts, so losses to surfaces and incomplete digestion matter far more than in a bulk experiment. This is where method development effort concentrates.
The approach also scales down gracefully. Larger regions give deeper proteomes and coarser spatial information; smaller regions invert that. Because the trade is continuous rather than stepwise, a study can be designed at whatever point on the curve the biology requires, which is a genuine advantage over methods with fixed resolution.
How Deep Can Single-Cell Proteomics Go?
Deeper than most people expect, and the figures have moved quickly enough that older impressions are misleading.
The baseline for cultured material is documented: mass spectrometry-based single-cell proteomics has made rapid progress and can now quantify more than 1,000 proteins in cultured cells. That is a real capability and it comes with a real caveat from the same source, namely that proteome depth, throughput, and the absence of spatial context have limited biological usefulness.
Approach | Material per Measurement | Reported Depth | Spatial Information |
Single-cell proteomics, cultured cells | One cell | More than 1,000 proteins quantified | None. Cells are dissociated |
Single-cell Deep Visual Proteomics in tissue | One cell slice | 1,700 proteins from a hepatocyte cell slice | Full. Position in the tissue is retained |
Deep Visual Proteomics with pooling | Multiple morphologically similar cells | Greater, by pooling to gain material | Cell-class rather than individual cell |
Region-level microdissection with LC-MS | A defined tissue region | Deepest of the four | Region-level, set by dissection precision |
Direct imaging of peptides on tissue | One pixel | Shallowest. Limited to abundant species | Highest, and continuous across the section |
Table 2. Proteome depth against spatial precision across the four approaches. Depth figures are as reported in the cited studies for specific tissues and configurations, not general capabilities.
Depth Is Bought With Material Read Table 2 downward, and the relationship is monotonic. Every increase in proteome depth comes from measuring more material, and every gain in spatial precision comes from measuring less. This is not a limitation awaiting better instruments; it is a consequence of there being a finite number of protein molecules in a given volume of tissue. Which makes the design question specific rather than general: what is the smallest spatial unit at which your biological question is still answerable, and what depth do you need at that unit? Answering those two together locates you on the table. Asking for maximum depth and maximum resolution simultaneously does not have an answer. |
Imaging-Guided Deep Visual Proteomics
The most significant recent development in this area combines microscopy, machine learning, and microdissection into one workflow, and it deserves understanding in some detail because it reframes what spatial proteomics can attempt.
Deep Visual Proteomics, introduced in Nature Biotechnology in 2022, combines artificial-intelligence-driven image analysis of cellular phenotypes with automated single-cell or single-nucleus laser microdissection and ultra-high-sensitivity mass spectrometry, linking protein abundance to cellular or subcellular phenotypes while preserving spatial context. The authors identify the key challenges as accurate definition of single-cell boundaries and cell classes, and the transfer of automatically defined features into proteomic samples ready for analysis, which they address with dedicated software coordinating the scanning and microdissection microscopes.
Applied to archived primary melanoma tissue, the method identified spatially resolved proteome changes as normal melanocytes transition to fully invasive melanoma, revealing pathways changing in a spatial manner as cancer progresses, including mRNA splicing dysregulation in metastatic vertical growth coinciding with reduced interferon signalling and antigen presentation. That the tissue was archival is worth noting: this is a method applicable to existing biobank material rather than requiring prospective collection.
The single-cell extension is where the most quotable result sits. Single-cell Deep Visual Proteomics, published in Nature Methods, integrates high-content imaging, laser microdissection, and multiplexed mass spectrometry, and resolved the context-dependent spatial proteome of murine hepatocytes at a depth of 1,700 proteins from a cell slice. Half of the measured proteome was differentially regulated in a spatial manner, with protein levels changing dramatically in proximity to the central vein. The authors then applied machine learning to proteome classes and images and inferred the spatial proteome from imaging data alone.
That half-the-proteome figure is the strongest available argument for doing spatial proteomics at all. A bulk measurement of the same tissue would have averaged across a spatial gradient affecting half of what it measured, which is not a subtle loss of resolution but a systematic misrepresentation of the biology.
Biological Fractionation, Named Honestly One important qualification about how depth is achieved in this family of methods. The approach overcomes depth and throughput limitations by pooling the required number of cells with similar morphological features and staining patterns, which its developers call biological fractionation, in order to identify statistically and analytically robust cellular phenotypes. That is a legitimate and powerful design, and it means much published work in this area measures morphologically homogeneous pools rather than individual cells. Worth knowing when reading depth figures, because a depth achieved from a pool does not transfer to a genuinely single-cell experiment. It is also the reason the method depends on prior marker knowledge: you have to know which cells are alike before you can pool them. |
Direct Imaging of Peptides and Proteins
The fourth approach dispenses with dissection entirely and images peptides or proteins directly from the section, in the same way lipids and metabolites are imaged. It offers the highest spatial resolution and the shallowest coverage of the four.
Three characteristics define it.
- On-tissue digestion is usually required. Intact proteins are difficult to desorb and detect efficiently, so an enzymatic digestion step is typically applied to the section before analysis, which adds a wet step and a delocalisation risk.
- Depth is limited to abundant species. A pixel contains very little material, so only relatively abundant peptides produce usable signal. This is the same coverage constraint that governs metabolite imaging, set out in Spatial Resolution vs. Sensitivity in MS Imaging: The Fundamental Trade-off.
- Identification is hard without fragmentation. A peptide mass alone is weak evidence of identity, so confident assignment usually requires combining imaging with a conventional experiment on comparable material.
A published single-cell protocol illustrates both the promise and the pattern. Work on MALDI imaging for spatial bottom-up proteomics at single-cell resolution used sublimed matrix with very small crystals to image proteins in single cells, detecting 89 peptide-like features from a single breast cancer cell, and identified 24 peptides corresponding to 17 proteins by combining the imaging data with conventional liquid chromatography and tandem MS on cell pellets. The pattern is instructive: imaging localises, and a solution-phase experiment identifies. Matrix and deposition considerations for this are covered in MALDI Imaging Mass Spectrometry: How It Works.
How Do You Choose an Approach?
From the spatial unit your question requires and the depth you need at that unit, in that order.
If Your Question Is | Use | Because |
What distinguishes this tissue region from that one, in depth | Microdissection with LC-MS | Deepest coverage available, and resolution is set by where you draw the boundary |
How does proteome vary with position within one cell type | Single-cell Deep Visual Proteomics | Retains position while reaching depth reported at 1,700 proteins in liver |
What proteins define these morphologically defined cell classes | Deep Visual Proteomics with pooling | Biological fractionation buys the depth that individual cells cannot supply |
Where are these specific known proteins, sensitively | Antibody-based imaging | Higher sensitivity for defined targets, and no dissection required |
What is the continuous distribution of abundant peptides | Direct MS imaging with on-tissue digestion | Only approach giving a continuous map rather than discrete samples |
Are there modified or variant proteoforms, and where | Any MS approach | Antibody methods generally cannot distinguish proteoforms at all |
Table 3. Matching the question to the approach. Most programmes end up combining two, typically a discovery approach followed by targeted validation.
Two closing observations. First, these approaches combine well and are frequently used in sequence: discovery by microdissection or imaging identifies which proteins and regions matter, then a targeted method validates them across a cohort. Second, spatial proteomics by mass spectrometry sits alongside rather than against the other spatial modalities, since it addresses a molecular class that overlaps only partially with them. Metabolites and lipids remain accessible to mass spectrometry alone, as covered in Spatial Metabolomics and Lipidomics by Mass Spectrometry Imaging, while the instrumentation and ionisation choices underlying all of it are set out in Mass Spectrometry Imaging: Principles, Techniques, and Applications.
This section develops each approach in turn. The practical workhorse, including low-input sample handling and achievable depth, is covered in Laser Capture Microdissection + LC-MS Proteomics. Sensitivity limits at single-cell input are treated in Single-Cell Proteomics by Mass Spectrometry. The imaging-guided workflow, its software requirements, and the marker-knowledge dependency are covered in Deep Visual Proteomics: Imaging-Guided Mass Spectrometry. And the direct comparison against antibody methods, on plex, sensitivity, modifications, throughput, and cost, is in MS-Based vs. Antibody-Based Spatial Proteomics: Choosing an Approach.
This article was produced under Separation Science's AI Editorial Guidelines.
